With patent losses on the horizon, Amgen refocuses its business strategy
The company's vice president and general manager of U.S. business operations explains how Amgen is going to deliver on its ...
Amgen price target raised to $294 from $275 at BofA
BofA raised the firm’s price target on Amgen (AMGN) to $294 from $275 and keeps an Underperform rating on the shares. For the last several ...
Amgen Inc. (AMGN) 45th Annual TD Cowen Health Care Conference (Transcript)
Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...
AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the second quarter of 2025. The dividend will be paid on June 6, 2025, to all stockholders of ...
7AMGN : Behind the Scenes of Amgen's Latest Options Trends
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale ...
Amgen Stock: Why I Still Rate It A 'Buy'
Amgen released financial results for the 4th quarter of 2024. Check out why I continue to cover AMGN stock with a 'Buy' ...
BioSpace2d
AstraZeneca, Amgen’s Phase III Win Strengthens Case for Tezspire Expansion
The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...
FiercePharma2d
Sinusitis data from Amgen, AZ's Tezspire spark 'best-in-disease' talk amid Sanofi, GSK competition
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
EXCLUSIVE: La La Anthony on Navigating Plaque Psoriasis, Her Partnership With Amgen and Moving Through Life ‘With More Confidence’
La La Anthony is partnering with Amgen to raise awareness and support those struggling with plaque psoriasis. The ...
Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025
Amgen (NasdaqGS:AMGN)'s recent affirmation of a $2.38 per share dividend for Q2 2025 could reflect investor confidence and ...